Creatinine is synthesized in the human body at the time of muscle contractions. The glomeruli of the kidney remove creatinine in the blood and secrete it into the urine. The creatinine test is one of the most sensitive tests employed for measuring the glomerular filtration rate of the kidney. Hence, the creatinine test is most widely used to assess the kidney functioning. Presently, in the fields of research and drug discovery, direct and automation-ready procedures are becoming popular for measuring creatinine concentration in biological samples. Hence, demand for use of the creatinine assay for diagnosis of kidney diseases is increasing globally. Creatinine assay kits are designed to directly measure creatinine in biological samples, without any pre-treatment. Major advances in the determination of creatinine levels contribute to diagnosis of early-stage kidney diseases. Rising demand for detection of presence of mycobacteria in urine and rise in geriatric population suffering from kidney malfunctioning are a few factors likely to boost the demand for creatinine assays in the near future. However, new developments in analytical methods and urology diagnostic techniques are paving the way for early diagnosis and treatment of kidney diseases.
High prevalence of chronic kidney disease (CKD) and diabetes, rising geriatric population, and increasing research and development initiatives are expected to drive the global creatinine assay market in the near future. Furthermore, advent in constituents of exogenous markers, rise in government funding, and large number of initiatives for clinical laboratories are also augmenting the global creatinine assay market. Serum creatinine assays are commonly employed in clinical chemistry laboratories worldwide. Favorable reimbursements and technologically advanced designs introduced by manufacturers (such as occlusive cuff or pumps with implants attached) in the global market are also likely to fuel the creatinine assay market during the forecast period.
The global creatinine assay market can be segmented based on assay type, sample type, end-user, and region. In terms of assay type, the market has been segmented into creatinine-pap test kits, ELISA test kits, Jaffe’s kinetic test kits, and others. The Jaffe’s kinetic test kits segment is likely to dominate the market during the forecast period, due to improving specificity of the reaction and challenges for clinical chemists. Based on sample type, the creatinine assay market can be classified into blood/serum, urine, and others. Blood/serum is a rapidly expanding segment owing to increase in the prevalence of chronic kidney disease worldwide. Rise in technical advancements in assays is also a major factor that is projected to fuel the blood/serum segment in the near future. In terms of end-user, the market can be segregated into research & academics, hospitals, pathology laboratories, and others. In terms of region, the global creatinine assay market can be segmented into North America, Europe, Asia Pacific, and Rest of World.
Geographically, North America dominates the global creatinine assay market, due to increasing geriatric patient population suffering from urinary disorders, growing number of devices receiving regulatory approvals, and rising demand for new and advanced assays. Rising incidence of chronic kidney disease and early-phase diagnosis of diabetes is driving the pharmaceutical industry. This, in turn, is expected to boost the creatinine assay market in North America from 2018 to 2026. Europe is the second-largest market for creatinine assay, due to favorable government policies regarding the development of health care infrastructure in the region. Expansion of research and development units and pathology labs in countries of Europe is also a major factor expected to drive the creatinine assay market in the region during the forecast period. The market in Asia Pacific is expected to expand at a high growth rate during the forecast period, due to increase in geriatric population with chronic kidney disease, rise in awareness among patients about kidney diseases, and surge in the per capita expenditure in the region. Additionally, economic growth in India and China is supporting the health care infrastructure as well as expansion of pharmaceutical companies and biotech labs in the country. This is likely to drive the creatinine assay market in Asia Pacific between 2018 and 2026.
Major players operating in the global creatinine assay market are Thermo Fisher Scientific Inc., Merck KGaA, Bioassay Systems LLC, Cell Biolabs Inc., Abbott Laboratories, Wako Pure Chemical Industries, Ltd, Abcam PLC, Biovision Inc., Tulip Diagnostics Private Limited, Genway Biotech, and Cayman Chemical.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.